S
TEVA icon

Steadtrust’s Teva Pharmaceuticals TEVA Stock Holding History

Steadtrust’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.23M Buy
36,300
+200
+0.6% +$6.66K 0.62% 38
2026
Q1 		$1.09M Sell
36,100
-1,200
-3% -$38.6K 0.62% 42
2025
Q4 		$1.16M Hold
37,300
– – 0.72% 36
2025
Q3 		$753K Buy
37,300
+13,700
+58% +$241K 0.51% 50
2025
Q2 		$396K Buy
+23,600
New +$381K 0.31% 81

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Steadtrust's TEVA Position: Q2 2026 in Review

Steadtrust increased its Teva Pharmaceuticals (TEVA) stake by 0.55% in Q2 2026, buying an estimated $6.66K and bringing the position to 36,300 shares worth $1.23M. The position accounts for 0.62% of the portfolio, ranked #38.

Steadtrust first reported a position in TEVA in Q2 2025 and has held it in 5 quarters since. 671 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Steadtrust held 36,300 shares of Teva Pharmaceuticals worth $1.23M as of Q2 2026.
  • Steadtrust bought 200 Teva Pharmaceuticals shares in Q2 2026, an estimated $6.66K.
  • Teva Pharmaceuticals made up 0.62% of Steadtrust's portfolio in Q2 2026, its #38 holding.
  • Steadtrust first reported a position in Teva Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 671 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Steadtrust's 13F filing for Q2 2026, filed 9 Jul 2026.